Previous researches have suggested that ZBTB48 has an auxo-action for progression colorectal cancer, and cervical cancer, and high expression of ZBTB48 is associated with poor prognosis in patients [47, 48]. This evidence concerns the gene ZBTB48 and cervical carcinoma.